Jiangsu Hengrui | 600276 - Current Liabilities


Jiangsu Hengrui reported CNY7.85B in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Cspc Pharmaceutical CNY 10.11B 478.47M Jun/2025
Kangmei Pharma CNY 5.81B 57.93M Sep/2025
Sh Fosun Pharma CNY 35.09B 936.39M Sep/2025
Sh Pharmaceutical CNY 138.99B 1.14B Sep/2025
Sino Biopharmaceutical CNY 24.85B 5.29B Jun/2025
Wuxi Apptec CNY 19.44B 1.08B Sep/2025
Zz Pientze Pharmaceu CNY 2.14B 1.06B Sep/2025